Dr. Jean-Louis Saillot has over 30 years of experience as a global biopharmaceutical executive and industry leader. Over his career at Celgene/BMS, Merck, Schering-Plough and SmithKline Beecham, he has made important contributions to over 20 successful NDA/MAA submissions.
He has played leadership roles across multiple functions, including Clinical Research, Clinical Operations, Regulatory Affairs, Quality & Compliance, Pharmacovigilance, and Portfolio & Project Management. His experience spans all drug developmental stages in multiple therapeutic areas, such as Immunology/Respiratory, CNS, Oncology, Cardiovascular, Infectious and Gastroenterology/Hepatitis. He has worked with various treatment modalities, including both small molecules and biologics.
Dr. Saillot has also held leadership positions at non-profit organizations, such as Vice Chairperson of the PhRMA (Pharmaceutical Research and Manufacturers of America) Clinical Leadership Committee and Chairperson of the PhRMA Clinical Research Technical Group. He was a member of the ICH E7 expert working group.
Dr. Saillot received his bachelor's degree from the Lycée Charles de Gaulle in London and his M.D. from Université Paris Sud (Paris XI) Medical School.